Withdrawal Policy
The Annals of Clinical Hypertension provides a structured and fair process for manuscript withdrawal or retraction during the “in press” stage—this includes accepted articles not yet formally published. These guidelines are designed to uphold ethical standards and reflect consensus from academic and library communities regarding scholarly practice.
Withdrawal applies solely to “Articles in Press,” which are manuscripts accepted for publication but not yet officially published. These may be withdrawn due to errors, unintended duplicate submissions, or ethical violations including multiple submissions, false authorship claims, plagiarism, or fraudulent data use—if identified by the editors.
Withdrawal Conditions & Restrictions
Authors must not submit the same manuscript to another journal during the 21 working-day review period. If they fail to honor this, the withdrawal policy becomes inapplicable.
| Withdrawal Timing | Fee (USD) |
|---|---|
| Before plagiarism check | $0 |
| After plagiarism check, before peer review | $349 |
| After peer review | $549 |
| At final proof stage | $749 |
Retractions may be warranted when serious ethical breaches are discovered—such as misleading authorship, plagiarism, data fraud, or redundant submissions. In such cases, rather than full removal, corrections may be issued. Retractions are guided by accepted norms from research and institutional bodies and involve consultation with reviewers and the editorial board.
Policy Context & Community Engagement
This withdrawal policy addresses common concerns and aligns with evolving academic and library best practices. The journal remains committed to periodically reviewing and refining this policy with input from the broader scholarly community.
For assistance with withdrawal or retraction matters, or to discuss policy details, please contact the editorial office at [email protected].